Expertise in
10
conditions

Rob S. Beanlands

40 Ruskin Street, 
Ottawa, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
10
conditions
40 Ruskin Street, 
Ottawa, ON, CA 

Overview

Rob Beanlands practices in Ottawa, Canada. Mr. Beanlands is highly rated in 10 conditions, according to our data. His top areas of expertise are Sarcoidosis, Coronary Heart Disease, Cardiomyopathy, Heart Transplant, and Heart Bypass Surgery.

His clinical research consists of co-authoring 295 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

40 Ruskin Street, Ottawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

The Canadian Study of Arterial Inflammation in Patients With Diabetes and Recent Vascular Events: EvaluatioN of Colchicine Effectiveness (CADENCE)
The Canadian Study of Arterial Inflammation in Patients With Diabetes and Recent Vascular Events: EvaluatioN of Colchicine Effectiveness (CADENCE)
Enrollment Status: Recruiting
Publish Date: April 22, 2024
Intervention Type: Drug
Study Drug: Colchicine
Study Phase: Phase 3
Spironolactone Therapy in Chronic Stable Right HF Trial
Spironolactone Therapy in Chronic Stable Right HF Trial
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Radiation, Diagnostic test, Drug
Study Drug: Spironolactone
Study Phase: Phase 4
Ontario Provincial Registry Project for Cardiac Viability Assessment Using FDG PET
Ontario Provincial Registry Project for Cardiac Viability Assessment Using FDG PET
Enrollment Status: Completed
Publish Date: May 08, 2024
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Project I-A of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Project I-A of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Other
Study Phase: Not Applicable
Optimization of Image Quality for Myocardial Perfusion Imaging With Rubidium-82 PET in Patients With Known or Suspected Ischemic Heart Disease (RUBY-DOSE)
Optimization of Image Quality for Myocardial Perfusion Imaging With Rubidium-82 PET in Patients With Known or Suspected Ischemic Heart Disease (RUBY-DOSE)
Enrollment Status: Unknown
Publish Date: November 29, 2023
Intervention Type: Drug
Computed Tomographic Coronary Angiography for Heart Failure Patients (CTA -HF) Project I-C of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Computed Tomographic Coronary Angiography for Heart Failure Patients (CTA -HF) Project I-C of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Enrollment Status: Completed
Publish Date: November 21, 2019
Intervention Type: Other
Study Phase: Not Applicable
Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure (OUTSMART-HF) Project I-B of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure (OUTSMART-HF) Project I-B of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Enrollment Status: Completed
Publish Date: November 21, 2019
Intervention Type: Other
Study Phase: Not Applicable
Evaluation of Cardiopulmonary Metabolism and Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Left Heart Disease
Evaluation of Cardiopulmonary Metabolism and Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Left Heart Disease
Enrollment Status: Terminated
Publish Date: August 31, 2018
Intervention Type: Radiation
Study Phase: Not Applicable
View 7 Less Clinical Trials

294 Total Publications

Myocardial Flow Reserve With 13N-Ammonia PET: From Quantification to Clinical Consequence.
Myocardial Flow Reserve With 13N-Ammonia PET: From Quantification to Clinical Consequence.
Journal: Circulation. Cardiovascular imaging
Published: April 06, 2026

Frequently Asked Questions about Rob S. Beanlands

Is Rob S. Beanlands a top-rated expert for Sarcoidosis?

MediFind is an objective health platform that identifies experts based on real-world data. Rob S. Beanlands is classified as an Elite expert for Sarcoidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rob S. Beanlands participate in research or clinical trials?

Yes. Rob S. Beanlands has published 294 articles and abstracts on conditions like Sarcoidosis. You can view a list of Rob S. Beanlands's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Beanlands's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 32 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile